Siegel, R. L., Miller, K. D., Fuchs, H. E. & Jemal, A. Cancer statistics, 2021. CA Cancer J. Clin. 71, 7–33 (2021).
Park, W., Chawla, A. & O’Reilly, E. M. Pancreatic cancer: a review. JAMA 326, 851–862 (2021).
National Cancer Institute. SEER Cancer Stat Facts: Pancreatic Cancer. https://seer.cancer.gov/statfacts/html/pancreas.html (2020).
Yuan, C. et al. Diabetes, weight change, and pancreatic cancer risk. JAMA Oncol. 6, e202948 (2020).
US Preventive Services Task Force. Screening for pancreatic cancer: US preventive services task force reaffirmation recommendation statement. JAMA 322, 438–444 (2019).
Singhi, A. D., Koay, E. J., Chari, S. T. & Maitra, A. Early detection of pancreatic cancer: opportunities and challenges. Gastroenterology 156, 2024–2040 (2019).
Corral, J. E., Mareth, K. F., Riegert-Johnson, D. L., Das, A. & Wallace, M. B. Diagnostic yield from screening asymptomatic individuals at high risk for pancreatic cancer: a meta-analysis of cohort studies. Clin. Gastroenterol. Hepatol. 17, 41–53 (2019).
Biller, L. H., Wolpin, B. M. & Goggins, M. Inherited pancreatic cancer syndromes and high-risk screening. Surg. Oncol. Clin. N. Am. 30, 773–786 (2021).
Lennon A. M., Vege S. S. Pancreatic cyst surveillance. Clin. Gastroenterol. Hepatol. 20, 1663–1667 (2022).
Sah, R. P. et al. Phases of metabolic and soft tissue changes in months preceding a diagnosis of pancreatic ductal adenocarcinoma. Gastroenterology 156, 1742–1752 (2019).
Khalaf, N. & Wolpin, B. M. Metabolic alterations as a signpost to early pancreatic cancer. Gastroenterology 156, 1560–1563 (2019).
Huang, B. Z. et al. New-onset diabetes, longitudinal trends in metabolic markers, and risk of pancreatic cancer in a heterogeneous population. Clin. Gastroenterol. Hepatol. 18, 1812–1821 e1817 (2020).
Baecker, A. et al. Do changes in health reveal the possibility of undiagnosed pancreatic cancer? Development of a risk-prediction model based on healthcare claims data. PLoS One 14, e0218580 (2019).
National Comprehensive Cancer Network. NCCN Guideline for Patients: Pancreatic Cancer. https://www.nccn.org/patients/guidelines/content/PDF/pancreatic-patient.pdf:11 (2021).
Risch, H. A., Yu, H., Lu, L. & Kidd, M. S. Detectable symptomatology preceding the diagnosis of pancreatic cancer and absolute risk of pancreatic cancer diagnosis. Am. J. Epidemiol. 182, 26–34 (2015).
Jeon, C. Y. et al. Prediction of pancreatic cancer in diabetes patients with worsening glycemic control. Cancer Epidemiol. Biomark. Prev. 31, 242–253 (2022).
Colditz, G. A., Manson, J. E. & Hankinson, S. E. The Nurses’ Health Study: 20-year contribution to the understanding of health among women. J. Women’s Health 6, 49–62 (1997).
Colditz, G. A. & Hankinson, S. E. The Nurses’ Health Study: lifestyle and health among women. Nat. Rev. Cancer 5, 388–396 (2005).
Belanger, C. F., Hennekens, C. H., Rosner, B. & Speizer, F. E. The nurses’ health study. Am. J. Nurs. 78, 1039–1040 (1978).
Belanger, C. et al. The nurses’ health study: current findings. Am. J. Nurs. 80, 1333 (1980).
Harvard School of Public Health. Health Professionals Follow-up Study. https://sites.sph.harvard.edu/hpfs/ (2020).
Campello, E., Ilich, A., Simioni, P. & Key, N. S. The relationship between pancreatic cancer and hypercoagulability: a comprehensive review on epidemiological and biological issues. Br. J. Cancer 121, 359–371 (2019).
Mayers, J. R. et al. Elevation of circulating branched-chain amino acids is an early event in human pancreatic adenocarcinoma development. Nat. Med 20, 1193–1198 (2014).
Danai, L. V. et al. Altered exocrine function can drive adipose wasting in early pancreatic cancer. Nature 558, 600–604 (2018).
Kenner, B. J. et al. Early detection of pancreatic cancer: applying artificial intelligence to electronic health records. Pancreas 50, 916–922 (2021).
Appelbaum, L. et al. Development and validation of a pancreatic cancer risk model for the general population using electronic health records: an observational study. Eur. J. Cancer 143, 19–30 (2021).
Placido, D. et al. Pancreatic cancer risk predicted from disease trajectories using deep learning. bioRxiv https://doi.org/10.1101/2021.06.27.449937 (2022).
Santos, R., Coleman, H. G., Cairnduff, V. & Kunzmann, A. T. Clinical prediction models for pancreatic cancer in general and at-risk populations: a systematic review. Am. J. Gastroenterol. 118, 26–40 (2022).
Porterfield, A., Engelbert, K. & Coustasse, A. Electronic prescribing: improving the efficiency and accuracy of prescribing in the ambulatory care setting. Perspect. Health Inf. Manag 11, 1g (2014).
Manca, D. P. Do electronic medical records improve quality of care? Yes. Can. Fam. Physician 61, 846–847 (2015). 850-841.
Payne, T. H. The electronic health record as a catalyst for quality improvement in patient care. Heart 102, 1782–1787 (2016).
Smith, D. H. et al. The impact of prescribing safety alerts for elderly persons in an electronic medical record: an interrupted time series evaluation. Arch. Intern. Med. 166, 1098–1104 (2006).
Abramson, E. L. et al. A long-term follow-up evaluation of electronic health record prescribing safety. J. Am. Med Inf. Assoc. 20, e52–e58 (2013).
Abramson, E. L., Barron, Y., Quaresimo, J. & Kaushal, R. Electronic prescribing within an electronic health record reduces ambulatory prescribing errors. Jt Comm. J. Qual. Patient Saf. 37, 470–478 (2011).
Uno, H. et al. Determining the time of cancer recurrence using claims or electronic medical record data. JCO Clin. Cancer Inf. 2, 1–10 (2018).
Tiwari, P. et al. Assessment of a machine learning model applied to harmonized electronic health record data for the prediction of incident atrial fibrillation. JAMA Netw. Open 3, e1919396 (2020).
Ratigan, A. R. et al. Longitudinal association of a medication risk score with mortality among ambulatory patients acquired through electronic health record data. J. Patient Saf. 17, 249–255 (2021).
Martin, A. et al. Development and validation of an asthma exacerbation prediction model using electronic health record (EHR) data. J. Asthma 57, 1339–1346 (2020).
Sharma, A., Smyrk, T. C., Levy, M. J., Topazian, M. A. & Chari, S. T. Fasting blood glucose levels provide estimate of duration and progression of pancreatic cancer before diagnosis. Gastroenterology 155, 490–500.e492 (2018).
Pelaez-Luna, M., Takahashi, N., Fletcher, J. G. & Chari, S. T. Resectability of presymptomatic pancreatic cancer and its relationship to onset of diabetes: a retrospective review of CT scans and fasting glucose values prior to diagnosis. Am. J. Gastroenterol. 102, 2157–2163 (2007).
Pannala, R. et al. Temporal association of changes in fasting blood glucose and body mass index with diagnosis of pancreatic cancer. Am. J. Gastroenterol. 104, 2318–2325 (2009).
Mueller, A. M., Meier, C. R., Jick, S. S. & Schneider, C. The potential of glycemic control and body weight change as early markers for pancreatic cancer in patients with long-standing diabetes mellitus: a case-control study. Pancreas 47, 807–815 (2018).
Sharma, A. et al. Model to determine risk of pancreatic cancer in patients with new-onset diabetes. Gastroenterology 155, 730–739.e733 (2018).
Snow, V. et al. Management of venous thromboembolism: a clinical practice guideline from the American College of Physicians and the American Academy of Family Physicians. Ann. Intern Med 146, 204–210 (2007).
Zhang, Y., Chan, A. T., Meyerhardt, J. A. & Giovannucci, E. L. Timing of Aspirin use in colorectal cancer chemoprevention: a prospective cohort study. J. Natl Cancer Inst. 113, 841–851 (2021).
Chan, A. T. et al. Long-term use of aspirin and nonsteroidal anti-inflammatory drugs and risk of colorectal cancer. JAMA 294, 914–923 (2005).
Michels, K. B. et al. Calcium channel blockers, cancer incidence, and cancer mortality in a cohort of U.S. women: the nurses’ health study. Cancer 83, 2003–2007 (1998).
Huang, T. et al. Hypertension, use of antihypertensive medications, and risk of epithelial ovarian cancer. Int J. Cancer 139, 291–299 (2016).
Li, Y., Hu, Y., Ley, S. H., Rajpathak, S. & Hu, F. B. Sulfonylurea use and incident cardiovascular disease among patients with type 2 diabetes: prospective cohort study among women. Diabetes Care 37, 3106–3113 (2014).
Pan, A. et al. Use of antidepressant medication and risk of type 2 diabetes: results from three cohorts of US adults. Diabetologia 55, 63–72 (2012).
Zhang, Y., Wu, K., Chan, A. T., Meyerhardt, J. A. & Giovannucci, E. L. Long-term statin use, total cholesterol level, and risk of colorectal cancer: a prospective cohort study. Am. J. Gastroenterol. 117, 158–166 (2022).
Xia, B. et al. Regular use of proton pump inhibitor and the risk of inflammatory bowel disease: pooled analysis of 3 prospective cohorts. Gastroenterology 161, 1842–1852.e1810 (2021).
Zhang, Y. et al. Long-term use of antihypertensive medications, hypertension and colorectal cancer risk and mortality: a prospective cohort study. Br. J. Cancer 127, 1974–1982 (2022).
Colditz, G. A. et al. Validation of questionnaire information on risk factors and disease outcomes in a prospective cohort study of women. Am. J. Epidemiol. 123, 894–900 (1986).
Feskanich, D. et al. Reproducibility and validity of food intake measurements from a semiquantitative food frequency questionnaire. J. Am. Diet. Assoc. 93, 790–796 (1993).
Hu, F. B. et al. Reproducibility and validity of dietary patterns assessed with a food-frequency questionnaire. Am. J. Clin. Nutr. 69, 243–249 (1999).
Wolf, A. M. et al. Reproducibility and validity of a self-administered physical activity questionnaire. Int J. Epidemiol. 23, 991–999 (1994).
Willett, W. C. et al. Reproducibility and validity of a semiquantitative food frequency questionnaire. Am. J. Epidemiol. 122, 51–65 (1985).
Willett, W. C. et al. The use of a self-administered questionnaire to assess diet four years in the past. Am. J. Epidemiol. 127, 188–199 (1988).
Willett W. C. In: Nutritional Epidemiology 3rd edn (Oxford University Press, 2013).
Stampfer, M. J. et al. Test of the national death index. Am. J. Epidemiol. 119, 837–839 (1984).
Rich-Edwards, J. W., Corsano, K. A. & Stampfer, M. J. Test of the national death index and equifax nationwide death search. Am. J. Epidemiol. 140, 1016–1019 (1994).
Yuan, C. et al. Validity of a dietary questionnaire assessed by comparison with multiple weighed dietary records or 24-hour recalls. Am. J. Epidemiol. 185, 570–584 (2017).
Rimm, E. B. et al. Reproducibility and validity of an expanded self-administered semiquantitative food frequency questionnaire among male health professionals. Am. J. Epidemiol. 135, 1114–1126 (1992).
Willett, W. Nutritional Epidemiology 3rd edn. (Oxford University Press, 2013).
Yuan, C. et al. Relative validity of nutrient intakes assessed by questionnaire, 24-hour recalls, and diet records as compared with urinary recovery and plasma concentration biomarkers: findings for women. Am. J. Epidemiol. 187, 1051–1063 (2018).
Joffe, M. M. & Rosenbaum, P. R. Invited commentary: propensity scores. Am. J. Epidemiol. 150, 327–333 (1999).
Rosenbaum, P. R. & Rubin, D. B. The central role of the propensity score in observational studies for causal effects. Biometrika 70, 41–55 (1983).